SUBSCRIBE
SUBSCRIBE
News   Drug Development

MicroIslet Inc. Provides Safety and Efficacy Data Update

July 2, 2008 | 
1 min read
SAN DIEGO--(BUSINESS WIRE)--MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data.
Preclinical
MORE ON THIS TOPIC
Female Project Manager running work on project timeline. Progress in business, Work process or work process, Timeline to success, Roadmap, Vector design illustration.
Obesity
Obesity Space Abuzz With Oral, Amylin Assets as Momentum Rides Into 2026
February 6, 2026
 · 
4 min read
 · 
Mark Zipkin
Insights
Programmable RNA 2.0: Beyond the First mRNA Revolution
February 5, 2026
 · 
1 min read
 · 
Jennifer Smith-Parker
Trend artwork 3D photo collage sketch image of young sad stressed lady with headache burnout deadline overloaded tired work in office.
Duchenne muscular dystrophy
Sarepta Saga Has ‘Gone on Too Long’ as Competitors Catch Up
February 5, 2026
 · 
5 min read
 · 
Dan Samorodnitsky
Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration
Immunology and inflammation
Lilly Eyes Pipeline in a Product as GLP-1s Move Into I&I
February 4, 2026
 · 
2 min read
 · 
Heather McKenzie